Organization
Xiamen Amoytop Biotech
4 clinical trials
2 abstracts
Clinical trial
A Multi-center, Randomized, Blinded Study to Evaluate the Efficacy and Safety of Peginterferon Alfa-2b Injection Combined With Tenofovir Disoproxil Fumarate Tablets in Patients With Chronic Hepatitis BStatus: Completed, Estimated PCD: 2023-11-30
Clinical trial
A Multicenter, Randomized, Open-label, Positive-controlled Phase 2 Study to Explore the Optimal Dose of Y- Shaped Pegylated Recombinant Growth Hormone (YPEG-rhGH) in Children With Short Stature (ISS, SGA, TS)Status: Completed, Estimated PCD: 2023-10-23
Clinical trial
A Multi-center, Randomized, Positive-control, Phase 2&3 Combined Study of Y-shape Pegylated Somatropin in Prepubertal Children With Growth Hormone Deficiency.Status: Completed, Estimated PCD: 2023-06-07
Clinical trial
A Multicenter, Randomized, Open-label, Phase 2 Study of YPEG-rhEPO in Patients Suffered From Anemia Due to Chronic Kidney Disease, Who Has Previously Treated With rhEPO and Maintains the Hemoglobin in a Stabilize StateStatus: Completed, Estimated PCD: 2022-01-05
Abstract
Determining MSI status by a one-step PCR melting curve analysis of Chinese-specific mononucleotide repeats.Org: China-Japan Friendship Hospital, Beijing InnoCare Pharma Tech, Department of Translational Medicine Research and New Technologies in Medicine and Surgery, Amoy Diagnostics Co., Ltd., Xiamen Amoytop Biotech,
Abstract
Influence of high COL19A1 expression on the effectiveness of neoadjuvant immunotherapy plus chemotherapy and long-term survival in patients with esophageal squamous cell carcinoma.Org: Guangdong Provincial People's Hospital, Guangzhou JOYO Pharma, China National Biotec Group, Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China,